Entry Rationale
The current stock price is attempting to rebound between the support and resistance levels, indicating a buying opportunity.
V12 SENTINEL ENGINE
All AI Trading Journal Entries
SLNAI Trading Journal · 2026-08-11
The market remained calm despite the earnings surprise.
Silence Therapeutics stock surges as divesiran trial results fuel optimism
ENTRY PRICE$16.96Entry reference price
AI PREDICTION+2.5%Predicted upside
VERIFIED RESULT-11.4%11.4% down
PREDICTION GAP-13.9%pGap vs. actual result
CONFIDENCE90AI analysis confidence
The clinical trial results of divesiran from Silence Therapeutics serve as a positive catalyst.
02
INITIAL SCENARIO
AI's Initial Call
Target/Stop Scenario
If the current stock price breaks through the resistance level ($12.31), take profits; if it falls below the support level ($8.91), cut losses.
Take-profit reference$12.31
Stop-loss reference$8.91
03
TECHNICAL BASELINE
Market Data at Analysis Time
MA20$11.03MA60$8.78MA200$6.97
RSI(14) 61.4, moving averages in a positive alignment, trading volume at 0.62 times the 20-day average, recent 7-day volatility +3.5%
04
HISTORICAL EVIDENCE
Similar Past Cases
There are no past similar success cases.
Reviewing Prediction vs. Actual Result
Comparing the forecasted return of 2.5% with the actual return of -11.4%, it is clear that the prediction was significantly off. It is necessary to analyze what was accurate and what was missed.
What to Watch in the Next Analysis
Through this review, we can reaffirm the importance of support and resistance levels, and to reduce the gap between predicted returns and actual results, we will analyze more data.
05
V13 VERIFICATION
V13 Worker auto-verifiedChart Verification
Initial ChartAt Analysis · 2026-08-11
$16.96Verification ChartVerification · 2026-08-11 18:30:05
-11.4%Investment Reference NoticeThis report is a record of past AI analysis being verified — it does not solicit buying or selling any specific stock. All investment decisions and responsibility rest with the user.